Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Boundless Bio Inc., 2 years.
Boundless Bio Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Annexon Inc. | Open-market sale | −5,565 | $5.42 | $30,162 |
| Feb 19, 2026 | Annexon Inc. | Grant or award | +62,500 | — | — |
| Feb 18, 2026 | Annexon Inc. | Open-market sale | −7,851 | $5.11 | $40,119 |
| Jul 14, 2025 | Annexon Inc. | Open-market sale | −1,117 | $2.58 | $2,882 |
| Feb 18, 2025 | Annexon Inc. | Open-market sale | −6,912 | $2.92 | $20,183 |
| Feb 13, 2025 | Annexon Inc. | Open-market sale | −1,786 | $2.98 | $5,322 |
| Jul 15, 2024 | Annexon Inc. | Open-market sale | −1,104 | $6.03 | $6,657 |
| Feb 27, 2024 | Annexon Inc. | Grant or award | +44,963 | — | — |
| Feb 20, 2024 | Annexon Inc. | Open-market sale | −2,593 | $5.53 | $14,339 |
| Feb 16, 2024 | Annexon Inc. | Grant or award | +39,000 | — | — |
| Feb 12, 2024 | Annexon Inc. | Open-market sale | −1,809 | $5.54 | $10,022 |
| Jul 11, 2023 | Annexon Inc. | Open-market sale | −1,057 | $3.84 | $4,059 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.